(Reuters) ? U.S. health regulators have approved an expanded label for Merck & Co's treatment for HIV for use with other antiretroviral drugs in children and adolescents.
The safety and effectiveness of the drug was evaluated in a clinical trial of 96 children and adolescents of ages 2-18 years with HIV-1 infection, the U.S. Food and Drug Administration said in a statement.
The drug, Isentress, was first approved for use in adult patients in October 2007.
(Reporting by Shailesh Kuber in Bangalore; Editing by Don Sebastian)
Source: http://us.rd.yahoo.com/dailynews/rss/parenting/*http%3A//news.yahoo.com/s/nm/20111221/hl_nm/us_merck
wilson ramos kidnapped mcqueary mike mcqueary joe paterno fired joe paterno fired glen campbell matt nathanson
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.